Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Chemotherapy causes permanent hair follicle damage by triggering stem cell loss.

Folate receptor β helps suppress the immune system in macrophages and affects cancer growth and hair health.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Skin reactions from cancer treatments might predict how well the treatments work.

Nivolumab can cause hair loss as a rare side effect.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

Six key genes can predict bladder cancer outcomes and may serve as prognostic biomarkers.

HPV infection is linked to better survival in advanced anal cancer, higher radiation doses improve survival, especially in HPV-negative patients, and prostaglandin E₂ pretreatment can protect mouse hair follicles from radiation damage.

CD201+ fascia progenitors are essential for wound healing and could be targeted for treating skin conditions.

Pantethine may boost the immune system's ability to fight sarcoma.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

Hair shaft miniaturization leads to hair follicle stem cell loss, suggesting Piezo1 as a potential treatment target.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

Aging and chronic inflammation weaken the immune system, increasing cancer and infection risks.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.